Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and tolerability of ABBV-951 in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABBV-951

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Phase 3 | Status: COMPLETED | Results posted: 2023-10-23